Alnylam Pharmaceuticals’ $1.035 Billion Notes Offering

Goodwin Procter advised Alnylam Pharmaceuticals, Inc. on the deal, while Davis Polk advised the representative of the initial purchasers.Alnylam Pharmaceuticals, Inc. announced its inaugural offering of…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now